John Lemkey
2018
In 2018, John Lemkey earned a total compensation of $849.9K as Chief Operating Officer at Odonate Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $64,000 |
|---|---|
| Option Awards | $577,995 |
| Salary | $200,000 |
| Other | $7,920 |
| Total | $849,915 |
Lemkey received $578K in option awards, accounting for 68% of the total pay in 2018.
Lemkey also received $64K in non-equity incentive plan, $200K in salary and $7.9K in other compensation.
Rankings
In 2018, John Lemkey's compensation ranked 9,936th out of 14,244 executives tracked by ExecPay. In other words, Lemkey earned more than 30.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,936 out of 14,244 | 30th |
Division Manufacturing | 4,014 out of 5,765 | 30th |
Major group Chemicals And Allied Products | 1,510 out of 2,128 | 29th |
Industry group Drugs | 1,275 out of 1,817 | 30th |
Industry Pharmaceutical Preparations | 980 out of 1,391 | 30th |
Source: SEC filing on June 24, 2019.
Lemkey's colleagues
We found two more compensation records of executives who worked with John Lemkey at Odonate Therapeutics in 2018.